In prostate cancer, sTn is detected in up to half of all high grade tumours [12,13], and sTn-MUC1 has been correlated with survival outcome and higher serum Prostate Specific Antigen (PSA) levels [55]. This evidence concerns the gene KLK3 and prostate carcinoma.